A new Sino-American joint venture for manufacturing
pharmaceuticals, HBBenda, has started operations in Guangshui,
China, after being granted Good Manufacturing Practice (GMP)
approval.
Much has been written on In-Pharmatechnologist.com about the
impact on China of accession to the World Trade Organisation and
the effects on the domestic pharmaceutical industry of the
resulting need to comply with international intellectual...
Foreign drugmakers are failing to win ground against their local
counterparts in China, despite investing considerable sums in the
country over the last few years.
China's packaging industry is currently undergoing a growth rate
that is set to turn the sector into one of the country's leading
industries, report Simon Pitman and Phil Taylor.
Switzerland's Roche is setting up an R&D centre in Shanghai in
a move which reflects the growing importance of the country as both
a market for pharmaceutical products and a site for drug research.